Crestone, Inc
Clinical trials sponsored by Crestone, Inc, explained in plain language.
-
New c. diff drug shows promise in early trial
Disease control CompletedThis study tested a new drug called CRS3123 against the standard treatment vancomycin for C. diff infection, a serious gut infection. 43 adults with a first or second infection took either CRS3123 or vancomycin. The goal was to see if CRS3123 is safe and can cure the infection as…
Phase: PHASE2 • Sponsor: Crestone, Inc • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Breakfast vs. pill: does food change how this drug works?
Knowledge-focused CompletedThis study looked at whether eating a high-fat meal changes how the body absorbs a single dose of the drug CRS3123. Seventeen healthy adults took the drug once after fasting and once after a high-fat meal. The goal was to see if food affects drug levels in the blood, which helps …
Phase: PHASE1 • Sponsor: Crestone, Inc • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC